Antibiotics Aren’t Profitable Enough for Big Pharma to Make More
10 May 2019
Public health experts are calling for new incentives to reward companies for bringing drugs that are effective against resistant strains to market.
Further reading: Bloomberg
Smart Innovations
Ambassador Network
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!